IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v583y2020i7814d10.1038_s41586-020-2434-2.html
   My bibliography  Save this article

Whole-genome sequencing of patients with rare diseases in a national health system

Author

Listed:
  • Ernest Turro

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus
    University of Cambridge)

  • William J. Astle

    (University of Cambridge
    Cambridge Biomedical Campus)

  • Karyn Megy

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Stefan Gräf

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Daniel Greene

    (Cambridge Biomedical Campus
    University of Cambridge)

  • Olga Shamardina

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Hana Lango Allen

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Alba Sanchis-Juan

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Mattia Frontini

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus
    University of Cambridge)

  • Chantal Thys

    (Center for Molecular and Vascular Biology, KU Leuven)

  • Jonathan Stephens

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Rutendo Mapeta

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Oliver S. Burren

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Kate Downes

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Matthias Haimel

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Salih Tuna

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Sri V. V. Deevi

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Timothy J. Aitman

    (Imperial College London
    University of Edinburgh)

  • David L. Bennett

    (John Radcliffe Hospital
    Oxford University Hospitals Trust)

  • Paul Calleja

    (University of Cambridge)

  • Keren Carss

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Mark J. Caulfield

    (Genomics England Ltd
    NIHR Biomedical Research Centre at Barts, Queen Mary University of London)

  • Patrick F. Chinnery

    (Cambridge Biomedical Campus
    University of Cambridge, Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Peter H. Dixon

    (King’s College London)

  • Daniel P. Gale

    (University College London
    UK Renal Registry)

  • Roger James

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Ania Koziell

    (King’s College London
    Guy’s & St Thomas’ NHS Foundation Trust)

  • Michael A. Laffan

    (Imperial College Healthcare NHS Trust
    Imperial College London)

  • Adam P. Levine

    (University College London)

  • Eamonn R. Maher

    (University of Cambridge, Cambridge Biomedical Campus
    Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Hugh S. Markus

    (University of Cambridge, Cambridge Biomedical Campus)

  • Joannella Morales

    (European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI))

  • Nicholas W. Morrell

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Andrew D. Mumford

    (University of Bristol
    University Hospitals Bristol NHS Foundation Trust)

  • Elizabeth Ormondroyd

    (Oxford University Hospitals Trust
    University of Oxford)

  • Stuart Rankin

    (University of Cambridge)

  • Augusto Rendon

    (Cambridge Biomedical Campus
    Genomics England Ltd)

  • Sylvia Richardson

    (University of Cambridge)

  • Irene Roberts

    (Oxford University Hospitals Trust
    University of Oxford
    University of Oxford)

  • Noemi B. A. Roy

    (Oxford University Hospitals Trust
    University of Oxford
    Oxford University Hospitals NHS Foundation Trust)

  • Moin A. Saleem

    (University of Bristol
    University Hospitals Bristol NHS Foundation Trust)

  • Kenneth G. C. Smith

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Hannah Stark

    (Cambridge Biomedical Campus
    University of Cambridge)

  • Rhea Y. Y. Tan

    (University of Cambridge, Cambridge Biomedical Campus)

  • Andreas C. Themistocleous

    (John Radcliffe Hospital)

  • Adrian J. Thrasher

    (UCL Great Ormond Street Institute of Child Health)

  • Hugh Watkins

    (University of Oxford
    Oxford University Hospitals NHS Foundation Trust
    University of Oxford)

  • Andrew R. Webster

    (Moorfields Eye Hospital NHS Trust
    University College London)

  • Martin R. Wilkins

    (Imperial College London)

  • Catherine Williamson

    (King’s College London
    Hammersmith Hospital, Imperial College Healthcare NHS Trust)

  • James Whitworth

    (University of Cambridge, Cambridge Biomedical Campus
    Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Sean Humphray

    (Illumina Cambridge)

  • David R. Bentley

    (Illumina Cambridge)

  • Nathalie Kingston

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Neil Walker

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • John R. Bradley

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus
    Cambridge Biomedical Campus
    Cambridge University Hospitals NHS Foundation Trust)

  • Sofie Ashford

    (Cambridge Biomedical Campus
    University of Cambridge)

  • Christopher J. Penkett

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • Kathleen Freson

    (Center for Molecular and Vascular Biology, KU Leuven)

  • Kathleen E. Stirrups

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus)

  • F. Lucy Raymond

    (Cambridge Biomedical Campus
    University of Cambridge, Cambridge Biomedical Campus)

  • Willem H. Ouwehand

    (Cambridge Biomedical Campus
    Cambridge Biomedical Campus
    Cambridge Biomedical Campus
    University of Cambridge)

Abstract

Most patients with rare diseases do not receive a molecular diagnosis and the aetiological variants and causative genes for more than half such disorders remain to be discovered1. Here we used whole-genome sequencing (WGS) in a national health system to streamline diagnosis and to discover unknown aetiological variants in the coding and non-coding regions of the genome. We generated WGS data for 13,037 participants, of whom 9,802 had a rare disease, and provided a genetic diagnosis to 1,138 of the 7,065 extensively phenotyped participants. We identified 95 Mendelian associations between genes and rare diseases, of which 11 have been discovered since 2015 and at least 79 are confirmed to be aetiological. By generating WGS data of UK Biobank participants2, we found that rare alleles can explain the presence of some individuals in the tails of a quantitative trait for red blood cells. Finally, we identified four novel non-coding variants that cause disease through the disruption of transcription of ARPC1B, GATA1, LRBA and MPL. Our study demonstrates a synergy by using WGS for diagnosis and aetiological discovery in routine healthcare.

Suggested Citation

  • Ernest Turro & William J. Astle & Karyn Megy & Stefan Gräf & Daniel Greene & Olga Shamardina & Hana Lango Allen & Alba Sanchis-Juan & Mattia Frontini & Chantal Thys & Jonathan Stephens & Rutendo Mapet, 2020. "Whole-genome sequencing of patients with rare diseases in a national health system," Nature, Nature, vol. 583(7814), pages 96-102, July.
    • Handle: RePEc:nat:nature:v:583:y:2020:i:7814:d:10.1038_s41586-020-2434-2
    DOI: 10.1038/s41586-020-2434-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-020-2434-2
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-020-2434-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Timofey Prodanov & Vikas Bansal, 2022. "Robust and accurate estimation of paralog-specific copy number for duplicated genes using whole-genome sequencing," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    2. Peter H. Dixon & Adam P. Levine & Inês Cebola & Melanie M. Y. Chan & Aliya S. Amin & Anshul Aich & Monika Mozere & Hannah Maude & Alice L. Mitchell & Jun Zhang & Jenny Chambers & Argyro Syngelaki & Je, 2022. "GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    3. Vincent Michaud & Eulalie Lasseaux & David J. Green & Dave T. Gerrard & Claudio Plaisant & Tomas Fitzgerald & Ewan Birney & Benoît Arveiler & Graeme C. Black & Panagiotis I. Sergouniotis, 2022. "The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    4. Molas-Gallart, Jordi & Woolley, Richard, 2022. "Research impact seen from the user side," INGENIO (CSIC-UPV) Working Paper Series 202201, INGENIO (CSIC-UPV).
    5. Mallory J. Owen & Sebastien Lefebvre & Christian Hansen & Chris M. Kunard & David P. Dimmock & Laurie D. Smith & Gunter Scharer & Rebecca Mardach & Mary J. Willis & Annette Feigenbaum & Anna-Kaisa Nie, 2022. "An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseases," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    6. Matt C. Danzi & Maike F. Dohrn & Sarah Fazal & Danique Beijer & Adriana P. Rebelo & Vivian Cintra & Stephan Züchner, 2023. "Deep structured learning for variant prioritization in Mendelian diseases," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    7. Marsha M. Wheeler & Adrienne M. Stilp & Shuquan Rao & Bjarni V. Halldórsson & Doruk Beyter & Jia Wen & Anna V. Mihkaylova & Caitlin P. McHugh & John Lane & Min-Zhi Jiang & Laura M. Raffield & Goo Jun , 2022. "Whole genome sequencing identifies structural variants contributing to hematologic traits in the NHLBI TOPMed program," Nature Communications, Nature, vol. 13(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:583:y:2020:i:7814:d:10.1038_s41586-020-2434-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.